OptimizeRx Corporation

(NASDAQ:OPRX)

Latest On OptimizeRx Corporation (OPRX):

Date/Time Type Description Signal Details
2023-05-11 09:05 ESTNewsOptimizeRx Corporation (OPRX) Q1 2023 Earnings Call TranscriptN/A
2023-05-10 19:14 ESTNewsOptimizeRx Non-GAAP EPS of -$0.09 misses by $0.01, revenue of $13M beats by $0.64MN/A
2023-05-10 05:58 ESTNewsOptimizeRx Q1 2023 Earnings PreviewN/A
2023-04-04 01:29 ESTNewsOptimizeRx Has A Good Growth Path AheadN/A
2023-03-14 08:26 ESTNewsOptimizeRx launches $15M stock buyback planN/A
2023-03-09 20:46 ESTNewsOptimizeRx bags contract with Hub services company for better patient accessN/A
2023-03-09 05:10 ESTNewsOptimizeRx Q4 results mixed, co sees FY 2023 Y/Y revenue growth below consensusN/A
2023-03-09 05:10 ESTNewsOptimizeRx Q4 top line miss, lackluster 2023 revenue guidance drives shares down 19%N/A
2023-03-09 05:10 ESTNewsOptimizeRx Corporation (OPRX) Q4 2022 Earnings Call TranscriptN/A
2022-11-09 10:21 ESTNewsOptimizeRx Corporation (OPRX) Q3 2022 Earnings Call TranscriptN/A
2022-11-08 17:11 ESTNewsOptimizeRx Non-GAAP EPS of $0.07 beats by $0.03, revenue of $15.1M beats by $0.08MN/A
2022-11-07 23:01 ESTNewsOptimizeRx Q3 2022 Earnings PreviewN/A
2022-10-25 15:02 ESTNewsOptimizeRx: A Digital Health Marketing Firm That Has Fallen On Hard TimesN/A
2022-10-12 08:35 ESTNewsOptimizeRx: A Top Candidate For My Speculative 'Bio Boom' PortfolioN/A
2022-08-10 21:45 ESTNewsOptimizeRx stock sinks 26% on Q2 miss, while FY22 outlook cut on life sciences sector woesN/A
2022-08-10 04:11 ESTNewsOptimizeRx Q2 Non-GAAP EPS, revenue misses, FY22 guidance below consensusN/A
2022-08-10 04:11 ESTNewsOptimizeRx Corporation (OPRX) CEO William Febbo on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-09 06:21 ESTNewsOptimizeRx Q2 2022 Earnings PreviewN/A
2022-07-26 19:41 ESTNewsOptimizeRx extends reach with Cooler Screens PartnershipN/A
2022-06-27 13:25 ESTNewsOptimizeRx: A Small-Cap Digital Health Technology Gem With Near-Term Inflection In ProfitabilityN/A
2022-06-26 19:34 ESTNewsOptimizeRx (OPRX) Investor Presentation - SlideshowN/A
2022-05-17 14:46 ESTNewsOptimizeRx authorizes $20M share repurchase programN/A
2022-05-05 07:30 ESTNewsOptimizeRx Non-GAAP EPS of -$0.01 in-line, revenue of $13.73M beats by $0.18MN/A
2022-05-05 07:29 ESTNewsOptimizeRx Corporation (OPRX) CEO William Febbo on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-03 18:55 ESTNewsOptimizeRx Q1 2022 Earnings PreviewN/A
2022-03-16 08:15 ESTNewsOptimizeRx to acquire specialty drug prescription platform EvincemedN/A
2022-02-25 12:37 ESTNewsOptimizeRx's (OPRX) CEO William Febbo on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-24 17:00 ESTNewsOptimizeRx Non-GAAP EPS of $0.22 beats by $0.18, revenue of $20.3M beats by $5.5MN/A
2022-02-24 00:04 ESTNewsOptimizeRx Q4 2022 Earnings PreviewN/A
2022-02-16 04:57 ESTNewsOptimizeRx announces preliminary Q4 resultsN/A
2021-11-10 13:38 ESTNewsOptimizeRx EPS misses by $0.04, beats on revenueN/A
2021-11-10 13:38 ESTNewsOptimizeRx's (OPRX) CEO William Febbo on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-09 14:32 ESTNewsOptimizeRx Q3 2021 Earnings PreviewN/A
2021-09-30 20:19 ESTNewsOptimizeRx names Edward Stelmakh as CFO and COON/A
2021-09-29 20:59 ESTNewsOptimizeRx jumps 11% on addition to SmallCap 600 indexN/A
2021-08-05 10:49 ESTNewsOptimizeRx Corporation (OPRX) CEO William Febbo on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-21 18:39 ESTNewsOptimizeRx inks collaboration agreement to drive new patient affordability initiativeN/A
2021-04-20 09:36 ESTNewsOptimizeRx Stock Is Just Getting StartedN/A
2021-03-17 05:40 ESTNewsOptimizeRx nabs 19 new enterprise-level engagements in Q1 leading to recurring revenueN/A
2021-03-02 12:13 ESTAnalyst RatingThe Analyst Target Price has increased from $65.33 to $75.33.Buy
2021-02-26 12:08 ESTAnalyst RatingThe Analyst Target Price has increased from $61.33 to $65.33.Buy
2021-02-26 04:22 ESTFinancialsCompany financials have been released.Neutral
2021-02-25 14:02 ESTEarnings EstimateAn EPS average of $0.07 is estimated for the quarter ending on June 30, 2021.Sell
2021-02-25 14:02 ESTEarnings EstimateAn EPS average of $0.78 is estimated for the 2022 year.Buy
2021-02-25 07:12 ESTNewsOptimizeRx EPS beats by $0.01, beats on revenueN/A
2021-02-25 07:10 ESTNewsOptimizeRx Corporation (OPRX) CEO William Febbo on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-10 16:32 ESTNewsOptimizeRx announces proposed public offeringN/A
2021-02-10 16:31 ESTNewsOptimizeRx priced its stock offeringN/A
2021-01-26 12:20 ESTAnalyst RatingThe Analyst Target Price has increased from $53.33 to $61.33.Buy
2021-01-25 20:45 ESTNewsOptimizeRx trades high on positive Q4 guidanceN/A

About OptimizeRx Corporation (OPRX):

OptimizeRx Corporation operates as a digital health company that provides communications solutions for life science companies, physicians, and patients. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, therapeutic support messages, and unbranded messages. The company also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, it operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform that allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, the company offers patient programs with treatment and affordability information, lifestyle and condition trackers, Internet device connectivity, forms, and surveys. OptimizeRx Corporation is headquartered in Rochester, Michigan.

OPRX Quotes by TradingView

See Advanced Chart

General

  • Name OptimizeRx Corporation
  • Symbol OPRX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryHealth Information Services
  • Full Time Employees 71
  • Last Split Factor1:3
  • Last Split Date2018-05-14
  • Fiscal Year EndDecember
  • IPO Date1996-10-22
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Technology
  • Gic SubIndustryHealth Care Technology
  • Web URLhttp://www.optimizerx.com
View More

Valuation

  • Forward PE 96.15
  • Price/Sales (Trailing 12 Mt.) 15.5
  • Price/Book (Most Recent Quarter) 15.23
  • Enterprise Value Revenue 17.34
  • Enterprise Value EBITDA 467.33
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $0.44
  • Next Year EPS Estimate $0.81
  • Next Quarter EPS Estimate $0.03
  • Profit Margin -5%
  • Operating Margin -3%
  • Return on Assets -1%
  • Return on Equity -5%
  • Revenue 43.31 million
  • Earnings Per Share $0.04
  • Revenue Per Share $2.92
  • Gross Profit 24.11 million
  • Quarterly Earnings Growth 122.6%
View More

Highlights

  • Market Capitalization 839.66 million
  • EBITDA 646895
  • PE Ratio -8.5
  • PEG Ratio 1.93
  • Analyst Target Price $75.33
  • Book Value Per Share $3.28
View More

Share Statistics

  • Shares Outstanding 16.81 million
  • Shares Float 14.36 million
  • % Held by Insiders 1791%
  • % Held by Institutions 65.76%
  • Shares Short 871014
  • Shares Short Prior Month 930303
  • Short Ratio 2.63
  • Short % of Float 5%
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 0.66
  • 52 Week High $63.98
  • 52 Week Low $6.51
  • 50 Day Moving Average 51.77
  • 200 Day Moving Average 32.49
View More

Dividends

  • Dividend Date 2018-05-14
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

OptimizeRx Corporation (OPRX) Dividend Calendar:

OPRX's last dividend payment was made to shareholders on May 14, 2018.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

OptimizeRx Corporation (OPRX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-24$N/A$0.16$0.163.23%
2020-09-302020-11-09$N/A$0.06$0.0455.75%
2020-06-302020-08-05$N/A$0.02-$0.03166.67%
2020-03-312020-05-04$N/A-$0.06-$0.03-100%
2019-12-312020-02-27$7.38 million-$0.03$0.01-700%
2019-09-302019-11-05$5 million-$0.05$0.08-164.52%
2019-06-302019-08-07$7.01 million$0.09$0.0816.13%
2019-03-312019-05-08$5.21 million$0.06$0.02166.67%
2018-12-312019-02-26$6.58 million$0.06$0.07-18.14%
2018-09-302018-11-05$5.42 million$0.07$0.0623%
2018-06-302018-08-07$5.1 million$0.07$0.03166.8%
2018-03-312018-05-02$4.11 million$0.03-$0.03205%
2017-12-312018-02-27$4.01 million$0.02-$0.03157%
2017-09-302017-11-02$3.1 million-$0.04-$0.03-43%
2017-06-302017-08-01$2.87 million-$0.03
2017-03-312017-05-03$2.15 million-$0.09
2016-12-312017-03-08$2.29 million-$0.04
2016-09-302016-11-07$1.79 million-$0.02
2016-06-302016-08-08$1.91 million-$0.03-$0.030%
2016-03-312016-05-09$1.76 million-$0.01-$0.0366.67%
2015-12-312016-03-15$2.02 million-$0.01
2015-09-302015-11-12$2.01 million$0.01
2015-06-302015-08-11$1.71 million-$0.01
2015-03-312015-05-14$1.49 million-$0.01
2014-12-312015-03-31$1.97 million$0.00$0.01-100%
2014-09-302014-11-13$1.82 million-$0.02
2014-06-302014-08-14$1.43 million-$0.01$0.03-122.67%
2014-03-312014-05-28$1.29 million-$0.12
2013-12-312013-12-31$1.53 million-$0.01
2013-09-302013-09-30$1.37 million$0.00
2013-06-302013-06-30$1.1 million$0.03
2013-03-312013-03-31$669000-$0.02
2012-12-312012-12-31$0.07
2012-09-302012-09-30-$0.02
2012-06-302012-06-30-$0.02
2012-03-312012-03-31-$0.06
2011-12-312011-12-31-$0.11
2011-09-302011-09-30$191593-$0.21
2011-06-302011-06-30$200174-$0.09
2011-03-312011-03-31-$0.05
2010-12-312010-12-31-$0.08
2010-09-302010-09-30-$0.11
2010-06-302010-06-30-$0.20
2010-03-312010-03-31-$0.06
2009-12-312009-12-31-$0.54
2009-09-302009-09-30-$0.12
2009-06-302009-06-30-$0.08
2009-03-312009-03-31-$0.33
2008-12-312008-12-31-$0.84
2008-09-302008-09-30-$0.04
2008-06-302008-06-30-$0.14
2008-03-312008-03-31-$158.21

OptimizeRx Corporation (OPRX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development N/A N/A N/A N/A N/A
Income Before Tax N/A N/A N/A -2.2 million -2.89 million
Selling General Administrative N/A N/A N/A N/A 5.76 million
Gross Profit N/A N/A N/A N/A 4.47 million
Ebit N/A N/A N/A N/A -2.32 million
Operating Income N/A N/A N/A -2.26 million -2.32 million
Income Tax Expense N/A N/A N/A N/A -897960
Total Revenue N/A N/A N/A N/A 7.38 million
Cost of Revenue N/A N/A N/A N/A 2.91 million
Total Other Income Expense Net N/A N/A N/A N/A -567278
Net Income From Continuing Operations N/A N/A N/A -2.2 million -1.99 million
Net Income Applicable to Common Shares 1.36 million -282894 -1.08 million -2.2 million -1.99 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments N/A N/A N/A N/A N/A
Change to Liabilities -203655 105896 -33471 -766603 530192
Total Cash Flow from Investing Activities -20256 -9061 -15937 -9.52 million -13718
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities N/A N/A 112152 113279 206324
Change to Operating Activities 1.52 million 1.51 million -1.23 million 310250 -824717
Change in Cash N/A N/A N/A -10.91 million -776453
Total Cash from Operating Activities -106598 127643 -3.74 million -1.5 million -969059
Depreciation N/A N/A N/A 536859 320055
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A 151719 266109
Other Cash Flow from Financing Activities -3 million -1.39 million N/A 301711 N/A
Change to Net Income 906827 850671 854512 252618 310244
Capital Expenditures N/A N/A N/A 26260 13718
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities N/A N/A N/A 12.61 million 11.78 million
Total Stockholder Equity N/A N/A N/A N/A 44.86 million
Other Current Liabilities 6.87 million 5.71 million N/A N/A 3.7 million
Total Assets N/A N/A N/A 56.24 million 56.64 million
Common Stock 15223 15072 14753 14647 14601
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings -35.63 million -36.99 million -36.71 million -35.63 million -33.42 million
Other Liabilities N/A N/A N/A 2.72 million 5.22 million
Other Assets 12859 16013 35943 16013 80727
Cash N/A N/A N/A 15.21 million 18.85 million
Total Current Liabilities 10.03 million 8.11 million N/A 9.47 million 6.11 million
Other Stockholder Equity N/A N/A N/A N/A N/A
Property, Plant & Equipment 594828 626715 660056 701967 735877
Total Current Assets 32.86 million 27.23 million N/A N/A 27.14 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 23.11 million 19.41 million 15.76 million 15.41 million 16.18 million
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 618250 480502 N/A N/A 492995

OptimizeRx Corporation (OPRX) Chart:

OptimizeRx Corporation (OPRX) News:

Below you will find a list of latest news for OptimizeRx Corporation (OPRX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

OptimizeRx Corporation (OPRX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-04-172.54.7CALL0 1769.28TRUE00
2025-04-1753.08CALL0 3362.91TRUE00
2025-04-177.50.78CALL0 604103.08TRUE00
2025-04-17100.05CALL0 205126.83FALSE00
2025-04-1712.50.1CALL0 41254.81FALSE00
2025-04-17150CALL0 0556.6FALSE00
2025-04-1717.50CALL0 0629.7FALSE00
2025-04-172.50.05PUT0 8515.11FALSE00
2025-04-1750.05PUT0 221413.72FALSE00
2025-04-177.50.2PUT0 6997.61FALSE00
2025-04-17102.7PUT0 18168.43TRUE00
2025-04-1712.53.7PUT0 1204.52TRUE00
2025-04-17156PUT0 1484.83TRUE00
2025-04-1717.50PUT0 0515.2TRUE00
2025-05-162.54.7CALL0 1232.16TRUE00
2025-05-1650CALL0 0121TRUE00
2025-05-167.51.05CALL2 58870.58TRUE-0.13-0.11
2025-05-16100.3CALL61 16586.49FALSE0.30
2025-05-1612.50CALL0 0112.27FALSE00
2025-05-16150CALL0 0212.79FALSE00
2025-05-1617.50CALL0 0240.87FALSE00
2025-05-162.50PUT0 0440.44FALSE00
2025-05-1650.15PUT0 44112.59FALSE00
2025-05-167.50.6PUT44 24394.09FALSE0.60
2025-05-16102.2PUT100 39994.17TRUE2.20
2025-05-1612.50PUT0 086.01TRUE00
2025-05-16150PUT0 0183.62TRUE00
2025-05-1617.50PUT0 0166.68TRUE00
2025-06-202.52.95CALL0 1298.22TRUE00
2025-06-2052.59CALL0 43101TRUE00
2025-06-207.51.45CALL0 8085.44TRUE00
2025-06-20100.65CALL0 5285.91FALSE00
2025-06-2012.50.2CALL0 2687.02FALSE00
2025-06-20150.09CALL0 296.13FALSE00
2025-06-2017.50CALL0 0120.44FALSE00
2025-06-202.50.05PUT0 12171.28FALSE00
2025-06-2050.25PUT0 2006108.61FALSE00
2025-06-207.51.2PUT0 70084.5FALSE00
2025-06-20100PUT0 082TRUE00
2025-06-2012.50PUT0 074.06TRUE00
2025-06-20150PUT0 0103.97TRUE00
2025-06-2017.50PUT0 0157.5TRUE00
2025-07-182.50CALL0 0168.25TRUE00
2025-07-1850CALL0 097.26TRUE00
2025-07-187.51.1CALL0 181.1TRUE00
2025-07-18100.6CALL0 21471.99FALSE00
2025-07-1812.50.35CALL4 081.65FALSE0.350
2025-07-18150CALL0 073.73FALSE00
2025-07-1817.50CALL0 0143.7FALSE00
2025-07-182.50.05PUT0 113272.08FALSE00
2025-07-1850PUT0 088.53FALSE00
2025-07-187.51.05PUT0 3678.44FALSE00
2025-07-18100PUT0 093.67TRUE00
2025-07-1812.50PUT0 070.32TRUE00
2025-07-18150PUT0 090.18TRUE00
2025-07-1817.50PUT0 0106.14TRUE00
2025-09-192.54.62CALL0 091.48TRUE00
2025-09-1953.5CALL0 2791.97TRUE00
2025-09-197.51.4CALL0 14356.57TRUE00
2025-09-19100.65CALL0 47074.34FALSE00
2025-09-1912.50.35CALL0 26374.65FALSE00
2025-09-19150.5CALL0 2371.12FALSE00
2025-09-1917.50CALL0 080.62FALSE00
2025-09-192.50.15PUT0 5224.55FALSE00
2025-09-1950.27PUT0 22784.75FALSE00
2025-09-197.51.5PUT0 6575.05FALSE00
2025-09-19100PUT0 067.69TRUE00
2025-09-1912.50PUT0 071.55TRUE00
2025-09-19150PUT0 063.06TRUE00
2025-09-1917.50PUT0 087.37TRUE00

Latest OPRX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST1$25.31
Jun 13, 2022 7:59 PM EST85$25.28
Jun 13, 2022 7:59 PM EST30$25.32
Jun 13, 2022 7:59 PM EST23$25.32
Jun 13, 2022 8:45 PM EST2$25.99

OptimizeRx Corporation (OPRX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016585/0001213900-20-016585-index.htm
2020-02-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1448431/000103347520000005/0001033475-20-000005-index.htm
2020-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020004998/0001213900-20-004998-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005137/0001213900-20-005137-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005258/0001213900-20-005258-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005495/0001213900-20-005495-index.htm
2020-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005596/0001213900-20-005596-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005688/0001213900-20-005688-index.htm
2020-03-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005874/0001213900-20-005874-index.htm
2020-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020005969/0001213900-20-005969-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006161/0001213900-20-006161-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006356/0001213900-20-006356-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006358/0001213900-20-006358-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006360/0001213900-20-006360-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006361/0001213900-20-006361-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006460/0001213900-20-006460-index.htm
2020-03-16NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405https://www.sec.gov/Archives/edgar/data/1448431/000121390020006534/0001213900-20-006534-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020006751/0001213900-20-006751-index.htm
2020-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020007331/0001213900-20-007331-index.htm
2020-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1448431/000121390020007491/0001213900-20-007491-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008137/0001213900-20-008137-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008138/0001213900-20-008138-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008139/0001213900-20-008139-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008140/0001213900-20-008140-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008316/0001213900-20-008316-index.htm
2020-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008456/0001213900-20-008456-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008624/0001213900-20-008624-index.htm
2020-04-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008867/0001213900-20-008867-index.htm
2020-04-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020008955/0001213900-20-008955-index.htm
2020-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020009315/0001213900-20-009315-index.htm
2020-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020009488/0001213900-20-009488-index.htm
2020-04-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020009800/0001213900-20-009800-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020010957/0001213900-20-010957-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020011117/0001213900-20-011117-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1448431/000121390020011158/0001213900-20-011158-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020011286/0001213900-20-011286-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020011394/0001213900-20-011394-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020012040/0001213900-20-012040-index.htm
2020-05-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020012894/0001213900-20-012894-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020013773/0001213900-20-013773-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020014108/0001213900-20-014108-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020014568/0001213900-20-014568-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020015899/0001213900-20-015899-index.htm
2020-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020015991/0001213900-20-015991-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016166/0001213900-20-016166-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016579/0001213900-20-016579-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016581/0001213900-20-016581-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016582/0001213900-20-016582-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016584/0001213900-20-016584-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016585/0001213900-20-016585-index.htm
2020-07-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020016870/0001213900-20-016870-index.htm
2020-07-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020017235/0001213900-20-017235-index.htm
2020-07-10144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020017236/0001213900-20-017236-index.htm
2020-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020017818/0001213900-20-017818-index.htm
2020-07-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020018238/0001213900-20-018238-index.htm
2020-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020018352/0001213900-20-018352-index.htm
2020-07-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020018775/0001213900-20-018775-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1448431/000121390020020375/0001213900-20-020375-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020020566/0001213900-20-020566-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020020802/0001213900-20-020802-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020020933/0001213900-20-020933-index.htm
2020-08-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020021320/0001213900-20-021320-index.htm
2020-08-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020021359/0001213900-20-021359-index.htm
2020-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020022333/0001213900-20-022333-index.htm
2020-08-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020023057/0001213900-20-023057-index.htm
2020-08-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020023388/0001213900-20-023388-index.htm
2020-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020025434/0001213900-20-025434-index.htm
2020-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020025765/0001213900-20-025765-index.htm
2020-09-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020026656/0001213900-20-026656-index.htm
2020-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020027474/0001213900-20-027474-index.htm
2020-10-01DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020029583/0001213900-20-029583-index.htm
2020-10-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020031051/0001213900-20-031051-index.htm
2020-10-16144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1448431/000121390020031790/0001213900-20-031790-index.htm
2020-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1448431/000121390020033259/0001213900-20-033259-index.htm

OptimizeRx Corporation (OPRX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of OptimizeRx Corporation (OPRX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1791%
Institutional Ownership: 6576%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-08-06DOUGLAS P BAKERCHIEF FINANCIAL OFFICERSell10,000.0017.01170,100.00100,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020020933/0001213900-20-020933-index.htm
2020-08-13DOUGLAS P BAKERCHIEF FINANCIAL OFFICERSell10,000.0018.00180,000.00100,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020022333/0001213900-20-022333-index.htm
2020-08-07DOUGLAS P BAKERCHIEF FINANCIAL OFFICERBuy10,000.002.4624,600.00110,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020020933/0001213900-20-020933-index.htm
2020-08-14DOUGLAS P BAKERCHIEF FINANCIAL OFFICERBuy10,000.002.4624,600.00110,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020022333/0001213900-20-022333-index.htm
2020-08-07GREGORY D WASSONDirectorBuy15,000.0017.49262,350.0015,000.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020021359/0001213900-20-021359-index.htm
2020-03-04WILLIAM J FEBBOCHIEF EXECUTIVE OFFICERBuy30,000.003.2196,300.00163,267.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020005495/0001213900-20-005495-index.htm
2020-03-30Patrick D SpanglerDirectorBuy2,784.0017,467.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020008140/0001213900-20-008140-index.htm
2020-06-30Patrick D SpanglerDirectorBuy1,937.0019,404.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020016584/0001213900-20-016584-index.htm
2020-06-24WILLIAM J FEBBOCHIEF EXECUTIVE OFFICERBuy45,261.003.21145,287.81208,528.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020015899/0001213900-20-015899-index.htm
2020-06-30WILLIAM J FEBBOCHIEF EXECUTIVE OFFICERBuy21,187.00229,719.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020016579/0001213900-20-016579-index.htm
2020-03-30Ellen O'Connor VosDirectorBuy2,784.0027,022.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020008138/0001213900-20-008138-index.htm
2020-03-30James Paul LangDirectorBuy2,784.0027,792.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020008137/0001213900-20-008137-index.htm
2020-03-31Ellen O'Connor VosDirectorBuy1,000.008.758,750.0028,022.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020008316/0001213900-20-008316-index.htm
2020-06-30James Paul LangDirectorBuy1,937.0029,729.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020016582/0001213900-20-016582-index.htm
2020-06-30Ellen O'Connor VosDirectorBuy1,937.0029,959.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020016585/0001213900-20-016585-index.htm
2020-03-30GUS D HALASDirectorBuy2,784.0059,960.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020008139/0001213900-20-008139-index.htm
2020-06-30GUS D HALASDirectorBuy1,937.0061,897.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020016581/0001213900-20-016581-index.htm
2020-09-02DOUGLAS P BAKERCHIEF FINANCIAL OFFICERSell10,000.0020.00200,000.0080,705.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020025434/0001213900-20-025434-index.htm
2020-07-16DOUGLAS P BAKERCHIEF FINANCIAL OFFICERSell6,667.0015.00100,005.0082,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020017818/0001213900-20-017818-index.htm
2020-06-03DOUGLAS P BAKERCHIEF FINANCIAL OFFICERBuy17,421.003.1554,876.1589,338.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020014108/0001213900-20-014108-index.htm
2020-07-17DOUGLAS P BAKERCHIEF FINANCIAL OFFICERBuy8,000.002.4619,680.0090,671.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020017818/0001213900-20-017818-index.htm
2020-09-02DOUGLAS P BAKERCHIEF FINANCIAL OFFICERBuy10,000.002.4624,600.0090,705.00https://www.sec.gov/Archives/edgar/data/1448431/000121390020025434/0001213900-20-025434-index.htm